(Q51908469)

17 April 2018

title

Experience with risperidone long-acting injection: results of a naturalistic observation study. (English)

1 reference

17 April 2018

1 reference

Paul N Deslandes

1

1 reference

17 April 2018

Arwel Thomas

series ordinal

2

1 reference

17 April 2018

Gwawr M Faulconbridge

series ordinal

3

1 reference

17 April 2018

Wendy C Davies

series ordinal

4

1 reference

17 April 2018

publication date

1 January 2007

1 reference

17 April 2018

International Journal of Psychiatry in Clinical Practice

published in

1 reference

17 April 2018

volume

11

1 reference

17 April 2018

issue

3

1 reference

17 April 2018

page(s)

207-211

1 reference

17 April 2018

Determinants of medication compliance in schizophrenia: empirical and clinical findings

cites work

1 reference

https://api.crossref.org/works/10.1080%2F13651500601091303

Relapse and rehospitalisation rates in patients with schizophrenia: effects of second generation antipsychotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13651500601091303

Relapse prevention in schizophrenia with new-generation antipsychotics: a systematic review and exploratory meta-analysis of randomized, controlled trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13651500601091303

Systematic meta-review of depot antipsychotic drugs for people with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13651500601091303

Long-acting risperidone: a review of its use in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13651500601091303

Long-acting injectable risperidone: efficacy and safety of the first long-acting atypical antipsychotic

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13651500601091303

Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13651500601091303

Prognostic indicators for early discontinuation of risperidone long-acting injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13651500601091303

Refractory schizophrenia and atypical antipsychotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13651500601091303

10.1080/13651500601091303

21 January 2018

Identifiers

DOI

1 reference

17 April 2018

1 reference

17 April 2018